Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001385508-22-000061)

Filing Details

Accession Number:: 0001385508-22-000061
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-05-17 16:02:13
Reporting Period:: 2022-05-16

Accepted Time:: 2022-05-17 16:02:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385508	Opiant Pharmaceuticals Inc.	OPNT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1363558	A Craig Collard	C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Blvd., Suite 400 Santa Monica CA 90401		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-05-16	27,150	$13.54	48,122	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $12.10 to $13.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.